Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Am J Kidney Dis. 2018 Aug 23;72(6):790–797. doi: 10.1053/j.ajkd.2018.06.012

Table 4.

Event rates for ESRD, overall mortality, and cancer mortality for stone formers and age- and gender-matched non-stone formers by stone former category

ESRD event rate
per 1000 person-years
Mortality event rate
per 1000 person-years
Cancer mortality event rate
per 1000 person-years
Stone Category SF Non-SF SF Non-SF SF Non-SF
Incident symptomatic 0.54 0.30 9.45 8.21 2.91 2.26
 Confirmed 0.55 0.30 9.82 8.40 2.89 2.25
 Suspected 0.50 0.28 7.97 7.42 2.99 2.30
Recurrent symptomatic 0.65 0.24 11.89 11.22 3.08 2.38
Asymptomatic 1.87 0.36 26.30 17.88 5.88 4.11
Bladder 1.69 1.35 67.00 47.84 15.20 8.32
Miscoded 1.50 0.18 14.81 12.40 4.61 3.25

SF, stone former; ESRD, end-stage renal disease